Aprea Therapeutics Inc (APRE)
5.21
-0.16
(-2.98%)
USD |
NASDAQ |
Apr 24, 16:00
5.21
0.00 (0.00%)
After-Hours: 19:20
Aprea Therapeutics Total Return Price: 5.21 for April 24, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 23, 2024 | 5.37 |
| April 22, 2024 | 5.120 |
| April 19, 2024 | 5.35 |
| April 18, 2024 | 5.61 |
| April 17, 2024 | 5.73 |
| April 16, 2024 | 5.85 |
| April 15, 2024 | 5.90 |
| April 12, 2024 | 5.71 |
| April 11, 2024 | 5.90 |
| April 10, 2024 | 6.20 |
| April 09, 2024 | 6.039 |
| April 08, 2024 | 6.20 |
| April 05, 2024 | 6.30 |
| April 04, 2024 | 6.17 |
| April 03, 2024 | 6.67 |
| April 02, 2024 | 6.60 |
| April 01, 2024 | 6.35 |
| March 28, 2024 | 6.69 |
| March 27, 2024 | 6.07 |
| March 26, 2024 | 5.92 |
| March 25, 2024 | 6.084 |
| March 22, 2024 | 6.12 |
| March 21, 2024 | 6.35 |
| March 20, 2024 | 6.50 |
| March 19, 2024 | 6.74 |
| Date | Value |
|---|---|
| March 18, 2024 | 6.55 |
| March 15, 2024 | 6.19 |
| March 14, 2024 | 5.31 |
| March 13, 2024 | 5.55 |
| March 12, 2024 | 6.16 |
| March 11, 2024 | 6.77 |
| March 08, 2024 | 7.13 |
| March 07, 2024 | 7.45 |
| March 06, 2024 | 8.29 |
| March 05, 2024 | 8.17 |
| March 04, 2024 | 8.40 |
| March 01, 2024 | 8.00 |
| February 29, 2024 | 8.46 |
| February 28, 2024 | 7.20 |
| February 27, 2024 | 7.27 |
| February 26, 2024 | 7.15 |
| February 23, 2024 | 7.24 |
| February 22, 2024 | 6.374 |
| February 21, 2024 | 6.28 |
| February 20, 2024 | 6.28 |
| February 16, 2024 | 5.828 |
| February 15, 2024 | 5.699 |
| February 14, 2024 | 5.97 |
| February 13, 2024 | 5.91 |
| February 12, 2024 | 6.40 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
2.886
Minimum
Jul 10 2023
990.60
Maximum
Dec 27 2019
190.99
Average
55.40
Median
Jan 06 2022
Total Return Price Benchmarks
| NeuBase Therapeutics Inc | 0.4333 |
| Stoke Therapeutics Inc | 11.64 |
| Processa Pharmaceuticals Inc | 1.65 |
| NovaBay Pharmaceuticals Inc | 0.0745 |
| Palatin Technologies Inc | 1.725 |